The role of lipopolysaccharide-binding protein in modulating the innate immune response

Microbes and Infection

Volumn 8, Issue 3, 2006, Pages 946-952

  Zweigner, Janine ^a   Schumann, Ralf R ^a   Weber, Joerg R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Gram positive pathogens; Immune response; Lipopolysaccharide; Lipopolysaccharide binding protein; SEPSIS

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BIOLOGICAL MARKER; GLYCOLIPID; LIPID TRANSFER PROTEIN; LIPOPEPTIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOTEICHOIC ACID; STAT3 PROTEIN;

AMINO ACID SEQUENCE; BACILLUS SUBTILIS; BACTERIAL CELL WALL; BACTERICIDAL ACTIVITY; CELL SURFACE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HAEMOPHILUS INFLUENZAE; HEPATOMA CELL; HUMAN; HUMORAL IMMUNITY; INFECTION; INNATE IMMUNITY; KLEBSIELLA; LIVER CELL; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STRUCTURE ANALYSIS; TRANSCRIPTION REGULATION; TREPONEMA;

ACUTE-PHASE PROTEINS; BACTERIAL INFECTIONS; CARRIER PROTEINS; HUMANS; IMMUNITY, NATURAL; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MYCOSES;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; KLEBSIELLA; MYCOBACTERIUM; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TREPONEMA;

EID: 33646024666     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.10.006     Document Type: Short Survey

References (63)

1. Medzhitov R., and Janeway Jr. C.A. Decoding the patterns of self and nonself by the innate immune system. Science 296 (2002) 298-300
2. Schumann R.R., Leong S.R., Flaggs G.W., Gray P.W., Wright S.D., Mathison J.C., Tobias P.S., and Ulevitch R.J. Structure and function of lipopolysaccharide binding protein. Science 249 (1990) 1429-1431
3. Tobias P.S., Soldau K., and Ulevitch R.J. Isolation of a lipopolysaccharide-binding acute-phase reactant from rabbit serum. J. Exp. Med. 164 (1986) 777-793
4. Su G.L., Freeswick P.D., Geller D.A., Wang Q., Shapiro R.A., Wan Y.H., Billiar T.R., Tweardy D.J., Simmons R.L., and Wan S.C. Molecular cloning, characterization, and tissue distribution of rat lipopolysaccharide binding protein. Evidence for extrahepatic expression. J. Immunol. 153 (1994) 743-752
5. Dentener M.A., Vreugdenhil A.C., Hoet P.H., Vernooy J.H., Nieman F.H., Heumann D., Janssen Y.M., Buurman W.A., and Wouters E.F. Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins. Am. J. Respir. Cell Mol. Biol. 23 (2000) 146-153
6. Weber J.R., Freyer D., Alexander C., Schroder N.W., Reiss A., Kuster C., Pfeil D., Tuomanen E.I., and Schuman R.R. Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding protein. Immunity 19 (2003) 269-279
7. Gray P.W., Corcorran A.E., Eddy Jr. R.L., Byers M.G., and Shows T.B. The genes for the lipopolysaccharide binding protein (LBP) and the bactericidal permeability increasing protein (BPI) are encoded in the same region of human chromosome 20. Genomics 15 (1993) 188-190
8. Desrumaux C., Labeur C., Verhee A., Tavernier J., Vandekerckhove J., Rosseneu M., and Peelman F. A hydrophobic cluster at the surface of the human plasma phospholipid transfer protein is critical for activity on high density lipoproteins. J. Biol. Chem. 276 (2001) 5908-5915
9. Bingle C.D., and Craven C.J. PLUNC: a novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum. Mol. Genet. 11 (2002) 937-943
10. Beamer L.J., Carroll S.F., and Eisenberg D. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science 276 (1997) 1861-1864
11. Schumann R.R., and Latz E. Lipopolysaccharide-binding protein. Chem. Immunol. 74 (2000) 42-60
12. Beamer L.J., Carroll S.F., and Eisenberg D. The BPI/LBP family of proteins: a structural analysis of conserved regions. Protein Sci. 7 (1998) 906-914
13. Lamping N., Hoess A., Yu B., Park T.C., Kirschning C.J., Pfeil D., Reuter D., Wright S.D., Herrmann F., and Schumann R.R. Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. J. Immunol. 157 (1996) 4648-4656
14. Beamer L.J., Carroll S.F., and Eisenberg D. The three-dimensional structure of human bactericidal/permeability-increasing protein: implications for understanding protein-lipopolysaccharide interactions. Biochem. Pharmacol. 57 (1999) 225-229
15. Schumann R.R., Kirschning C.J., Unbehaun A., Aberle H.P., Knope H.P., Lamping N., Ulevitch R.J., and Herrmann F. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol. Cell. Biol. 16 (1996) 3490-3503
16. Geller D.A., Kispert P.H., Su G.L., Wang S.C., Di Silvio M., Tweardy D.J., Billiar T.R., and Simmons R.L. Induction of hepatocyte lipopolysaccharide binding protein in models of sepsis and the acute-phase response. Arch. Surg. 128 (1993) 22-27
17. Hallatschek W., Fiedler G., Kirschning C.J., Creutzburg F., Lamping N., Nussler A., and Schumann R.R. Inhibition of hepatic transcriptional induction of lipopolysaccharide-binding protein by transforming-growth-factor beta 1. Eur. J. Immunol. 34 (2004) 1441-1450
18. Zweigner J., Gramm H.J., Singer O.C., Wegscheider K., and Schumann R.R. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 98 (2001) 3800-3808
19. Froon A.H., Dentener M.A., Greve J.W., Ramsay G., and Buurman W.A. Lipopolysaccharide toxicity-regulating proteins in bacteremia. J. Infect. Dis. 171 (1995) 1250-1257
20. Lemaire L.C., van Lanschot J.J., van der Poll T., Buurman W.A., van Deventer S.J., and Gouma D.J. Lymph of patients with a systemic inflammatory response syndrome inhibits lipopolysaccharide-induced cytokine production. J. Infect. Dis. 178 (1998) 883-886
21. Opal S.M., Palardy J.E., Marra M.N., Fisher Jr. C.J., McKelligon B.M., and Scott R.W. Relative concentrations of endotoxin-binding proteins in body fluids during infection. Lancet 344 (1994) 429-431
22. Martin T.R., Rubenfeld G.D., Ruzinski J.T., Goodman R.B., Steinberg K.P., Leturcq D.J., Moriarty A.M., Raghu G., Baughman R.P., and Hudson L.D. Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 155 (1997) 937-944
23. Roos T., Martin T.R., Ruzinski J.T., Leturcq D.J., Hillier S.L., Patton D.L., and Eschenbach D.A. Lipopolysaccharide binding protein and soluble CD14 receptor protein in amniotic fluid and cord blood in patients at term. Am. J. Obstet. Gynecol. 177 (1997) 1230-1237
24. Hailman E., Lichenstein H.S., Wurfel M.M., Miller D.S., Johnson D.A., Kelley M., Busse L.A., Zukowski M.M., and Wright S.D. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179 (1994) 269-277
25. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
26. Martin T.R., Mathison J.C., Tobias P.S., Leturcq D.J., Moriarty A.M., Maunder R.J., and Ulevitch R.J. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs. J. Clin. Invest. 90 (1992) 2209-2219
27. Pugin J., Schurer-Maly C.C., Leturcq D., Moriarty A., Ulevitch R.J., and Tobias P.S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 2744-2748
28. Tobias P.S., Soldau K., Gegner J.A., Mintz D., and Ulevitch R.J. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270 (1995) 10482-10488
29. Yu B., and Wright S.D. Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14. J. Biol. Chem. 271 (1996) 4100-4105
30. Gegner J.A., Ulevitch R.J., and Tobias P.S. Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J. Biol. Chem. 270 (1995) 5320-5325
31. Fan M.H., Klein R.D., Steinstraesser L., Merry A.C., Nemzek J.A., Remick D.G., Wang S.C., and Su G.L. An essential role for lipopolysaccharide-binding protein in pulmonary innate immune responses. Shock 18 (2002) 248-254
32. Wright S.D., Tobias P.S., Ulevitch R.J., and Ramos R.A. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J. Exp. Med. 170 (1989) 1231-1241
33. Lazou Ahren I., Bjartell A., Egesten A., and Riesbeck K. Lipopolysaccharide-binding protein increases toll-like receptor 4-dependent activation by nontypeable Haemophilus influenzae. J. Infect. Dis. 184 (2001) 926-930
34. van Langevelde P., van Dissel J.T., Ravensbergen E., Appelmelk B.J., Schrijver I.A., and Groeneveld P.H. Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and biological reactivities. Antimicrob. Agents Chemother. 42 (1998) 3073-3078
35. Greenberg J.W., Fischer W., and Joiner K.A. Influence of lipoteichoic acid structure on recognition by the macrophage scavenger receptor. Infect. Immun. 64 (1996) 3318-3325
36. Behr T., Fischer W., Peter-Katalinic J., and Egge H. The structure of pneumococcal lipoteichoic acid. Improved preparation, chemical and mass spectrometric studies. Eur. J. Biochem. 207 (1992) 1063-1075
37. Schroder N.W., Morath S., Alexander C., Hamann L., Hartung T., Zahringer U., Gobel U.B., Weber J.R., and Schumann R.R. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278 (2003) 15587-15594
38. Schroder N.W., Pfeil D., Opitz B., Michelsen K.S., Amberger J., Zahringer U., Gobel U.B., and Schumann R.R. Activation of mitogen-activated protein kinases p42/44, p38, and stress-activated protein kinases in myelo-monocytic cells by Treponema lipoteichoic acid. J. Biol. Chem. 276 (2001) 9713-9719
39. Schroder N.W., Opitz B., Lamping N., Michelsen K.S., Zahringer U., Gobel U.B., and Schumann R.R. Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids. J. Immunol. 165 (2000) 2683-2693
40. Fan X., Stelter F., Menzel R., Jack R., Spreitzer I., Hartung T., and Schutt C. Structures in Bacillus subtilis are recognized by CD14 in a lipopolysaccharide binding protein-dependent reaction. Infect. Immun. 67 (1999) 2964-2968
41. Vignal C., Guerardel Y., Kremer L., Masson M., Legrand D., Mazurier J., and Elass E. Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-alpha and IL-8 secretion by a CD14-toll-like receptor 2-dependent mechanism. J. Immunol. 171 (2003) 2014-2023
42. Schroder N.W., Heine H., Alexander C., Manukyan M., Eckert J., Hamann L., Gobel U.B., and Schumann R.R. Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J. Immunol. 173 (2004) 2683-2691
43. Gallay P., Heumann D., Le Roy D., Barras C., and Glauser M.P. Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 7922-7926
44. Le Roy D., Di Padova F., Tees R., Lengacher S., Landmann R., Glauser M.P., Calandra T., and Heumann D. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14. J. Immunol. 162 (1999) 7454-7460
45. Wurfel M.M., Monks B.G., Ingalls R.R., Dedrick R.L., Delude R., Zhou D., Lamping N., Schumann R.R., Thieringer R., Fenton M.J., Wright S.D., and Golenbock D. Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J. Exp. Med. 186 (1997) 2051-2056
46. Jack R.S., Fan X., Bernheiden M., Rune G., Ehlers M., Weber A., Kirsch G., Mentel R., Furll B., Freudenberg M., Schmitz G., Stelter F., and Schutt C. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 389 (1997) 742-745
47. Fierer J., Swancutt M.A., Heumann D., and Golenbock D. The role of lipopolysaccharide binding protein in resistance to Salmonella infections in mice. J. Immunol. 168 (2002) 6396-6403
48. Knapp S., de Vos A.F., Florquin S., and Golenbock D.T. T. van der Poll, Lipopolysaccharide binding protein is an essential component of the innate immune response to Escherichia coli peritonitis in mice. Infect. Immun. 71 (2003) 6747-6753
49. Lamping N., Dettmer R., Schroder N.W., Pfeil D., Hallatschek W., Burger R., and Schumann R.R. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. J. Clin. Invest. 101 (1998) 2065-2071
50. Wurfel M.M., Kunitake S.T., Lichenstein H., Kane J.P., and Wright S.D. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J. Exp. Med. 180 (1994) 1025-1035
51. Harris H.W., Grunfeld C., Feingold K.R., and Rapp J.H. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J. Clin. Invest. 86 (1990) 696-702
52. Vreugdenhil A.C., Rousseau C.H., Hartung T., Greve J.W., van't Veer C., and Buurman W.A. Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. J. Immunol. 170 (2003) 1399-1405
53. Levine D.M., Parker T.S., Donnelly T.M., Walsh A., and Rubin A.L. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 12040-12044
54. Pajkrt D., Doran J.E., Koster F., Lerch P.G., Arnet B., van der Poll T., ten Cate J.W., and van Deventer S.J. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J. Exp. Med. 184 (1996) 1601-1608
55. Hamann L., Alexander C., Stamme C., Zahringer U., and Schumann R.R. Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms. Infect. Immun. 73 (2005) 193-200
56. Mueller M., Brandenburg K., Dedrick R., Schromm A.B., and Seydel U. Phospholipids inhibit lipopolysaccharide (LPS)-induced cell activation: a role for LPS-binding protein. J. Immunol. 174 (2005) 1091-1096
57. Gutsmann T., Muller M., Carroll S.F., MacKenzie R.C., Wiese A., and Seydel U. Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. Infect. Immun. 69 (2001) 6942-6950
58. Pavcnik-Arnol M., Hojker S., and Derganc M. Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein. Intensive Care Med. 30 (2004) 1454-1460
59. Behrendt D., Dembinski J., Heep A., and Bartmann P. Lipopolysaccharide binding protein in preterm infants. Arch. Dis. Child. Fetal. Neonatal. Ed. 89 (2004) F551-F554
60. Oude Nijhuis C.S., Vellenga E., Daenen S.M., van der Graaf W.T., Gietema J.A., Groen H.J., Kamps W.A., and de Bont E.S. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients. Intensive Care Med. 29 (2003) 2157-2161
61. Reichelt U., Jung R., Nierhaus A., and Tsokos M. Serial monitoring of interleukin-1beta, soluble interleukin-2 receptor and lipopolysaccharide binding protein levels after death A comparative evaluation of potential postmortem markers of sepsis. Int. J. Legal Med. 119 (2005) 80-87
62. Blairon L., Wittebole X., and Laterre P.F. Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections. J. Infect. Dis. 187 (2003) 287-291
63. Opal S.M., Scannon P.J., Vincent J.L., White M., Carroll S.F., Palardy J.E., Parejo N.A., Pribble J.P., and Lemke J.H. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J. Infect. Dis. 180 (1999) 1584-1589